HEXAGON CAPITAL PARTNERS LLC – Novo Nordisk A/S Transaction History
HEXAGON CAPITAL PARTNERS LLC portfolio value:
$225,000
portfolio value
HEXAGON CAPITAL PARTNERS LLC quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.24% | 349 shares | 12K | $99.63 | 2.26K |
| Q2 2022 | share | Increase | +18.01% | 292 shares | 33K | $111.43 | 1.91K |
| Q1 2022 | share | Increase | +1.00% | 16 shares | 0 | $111.05 | 1.62K |
| Q4 2021 | share | 0.00% | 0 shares | 26K | $111.45 | 1.60K | |
| Q3 2021 | share | Increase | +1.84% | 29 shares | 22K | $96.01 | 1.60K |
| Q2 2021 | share | 0.00% | 0 shares | 26K | $83.32 | 1.57K | |
| Q1 2021 | share | Increase | +2.74% | 42 shares | -1K | $67.06 | 1.57K |
| Q4 2020 | share | Decrease | -1.29% | -20 shares | 6K | $68.52 | 1.53K |
| Q3 2020 | share | Increase | 0.00% | 1.55K shares | 101K | $68.1 | 1.55K |